Da disse reaktioner er immunmedierede, kan patienter, der for nylig har været behandlet med hirudin eller hirudinanaloger, have en øget risiko.
As these reactions are immune-mediated, patients with recent exposure to hirudin or hirudin analog may be at an increased risk.